v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (9,102,000) $ (2,878,000)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Stock-based compensation 726,000 456,000
Depreciation and amortization 416,000 358,000
Amortization of deferred costs 134,000 1,252,000
Non-cash operating lease expense 202,000 140,000
Changes in operating assets and liabilities:    
Accounts receivable 131,000 (209,000)
Inventories (345,000) 161,000
Deferred costs (864,000) (595,000)
Prepaid expenses and other current assets 553,000 41,000
Accounts payable 59,000 (51,000)
Accrued and other current liabilities 1,120,000 (332,000)
Deferred revenue 657,000 (1,300,000)
Operating lease liabilities (179,000) (86,000)
Net cash used in operating activities (6,492,000) (3,043,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (1,140,000) (34,000)
Net cash used in investing activities (1,140,000) (34,000)
Cash flows from financing activities:    
Issuance of common stock in connection with a stock purchase agreement 2,389,000 0
Payment of financing costs in connection with a stock purchase agreement (268,000) 0
Proceeds from exercise of stock options 2,000 8,000
Capital contributions from Amprius Holdings 0 247,000
Payment of transaction and issuance costs in connection with Business Combination and PIPE investment 0 (51,000)
Net cash provided by financing activities 2,123,000 204,000
Net decrease in cash, cash equivalents and restricted cash (5,509,000) (2,873,000)
Cash, cash equivalents and restricted cash, beginning of period 69,752,000 11,489,000
Cash, cash equivalents and restricted cash, end of period 64,243,000 8,616,000
Reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets:    
Cash and cash equivalents 64,187,000 8,616,000
Restricted cash included in other assets 56,000 0
Total cash, cash equivalents and restricted cash $ 64,243,000 $ 8,616,000

Source

PDF HTML
ZIP XLS XBRL